| Diabetes duration |
<1 year |
1-4 years |
5-10 years |
1-4 years |
>20 years |
| |
n=22 |
n=69 |
n=81 |
n=100 |
n=71 |
| Amylin, pM/dL, median |
26.2 |
28.2 |
26 |
17.9 |
13 |
| (Q1, Q3)** |
(13.4, 69.6) |
(15.8, 57.3) |
(11.4, 48.0) |
(9.9, 41.4) |
(5.8, 29.2) |
| Insulin treatment, n (%)*** |
0 (0.0) |
6 (8.7) |
18 (22.2) |
38 (38.0) |
37 (52.1) |
| Cardiovascular disease, n (%)* |
13 (59.1) |
24 (35.8) |
42 (52.5) |
56 (56.6) |
44 (63.8) |
| Stroke, n (%) |
3 (13.6) |
14 (20.3) |
19 (23.1) |
31 (31.3) |
20 (29.4) |
Diabetic subjects are divided into three subgroups based on disease duration:<1 year; 1-4 years; 5-9 years; 10-20 years and >20 years. n/total with Fisher exact test
or mean ± SD with ANOVA test or is used to describe the normal distributions and comparisons of those with insulin treatment, amylin concentration and the vascular
complications across five subgroups.
P values for the statistical significance are shown with *p<0.05; **p<0.001; ***p<0.0001 |
